Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis-Reference-Cited by-同舟云学术

Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis

Published:2015-12-01 Issue:12 Volume:72 Page:1433
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Cohen Jeffrey¹,Belova Anna²,Selmaj Krzysztof³,Wolf Christian⁴,Sormani Maria Pia⁵,Oberyé Janine⁶,van den Tweel Evelyn⁶,Mulder Roel⁶,Koper Norbert⁶,Voortman Gerrit⁶,Barkhof Frederik⁷,

Affiliation:

1. Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio

2. Functional Diagnostics, Research Institute of Traumatology and Orthopedics, Nizhniy Novgorod, Russian Federation

3. Neurology Center Lodz, Lodz, Poland

4. Lycalis sprl, Brussels, Belgium

5. Department of Health Sciences, University of Genoa, Genoa, Italy

6. Synthon BV, Nijmegen, the Netherlands

7. Image Analysis Center, Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tolerability and Acceptance of Switching from Brand to Generic Glatiramer Acetate in Multiple Sclerosis;Journal of Clinical Medicine;2024-05-09

2. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-01-04

3. Novel liposomal glatiramer acetate: Preparation and immunomodulatory evaluation in murine model of multiple sclerosis;International Journal of Pharmaceutics;2023-12

4. Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-11-30

5. Disease modifying therapy and pregnancy outcomes in multiple sclerosis: A systematic review and meta-analysis;Journal of Neuroimmunology;2023-10